Search - tctmd.com

Displaying 881 - 900 of 1554

Sort: Relevancy | Date

Apps? Wearables? Probing Mobile Tech’s Potential to Boost Cardiac Rehab

News Conference News WCC 2018

Apps? Wearables? Probing Mobile Tech’s Potential to Boost Cardiac Rehab

December 07, 2018

Marathons and Myocardium: Cardiac Biomarkers Rise in Amateur Runners Tackling Longer Distances

News Daily News

Marathons and Myocardium: Cardiac Biomarkers Rise in Amateur Runners Tackling Longer Distances

December 04, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

November 30, 2018

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

News Daily News

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

November 29, 2018

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

Aspirin Should Play Limited Role in Primary Prevention: Review

News Daily News

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

News Daily News

FDA Allows Claim About Oleic Acid’s Possible Heart Benefits on Labeling

November 19, 2018

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

News Conference News AHA 2018

Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest

Yael L. Maxwell

November 16, 2018

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

November 15, 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

Endoscopic Vein-Graft Harvest for CABG Associated With Similar MACE, Less Pain vs Open Procedure: REGROUP

News Conference News AHA 2018

Endoscopic Vein-Graft Harvest for CABG Associated With Similar MACE, Less Pain vs Open Procedure: REGROUP

Yael L. Maxwell

November 11, 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

News Conference News AHA 2018

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

November 10, 2018

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

News Daily News

ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom

Michael O'Riordan

November 07, 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

November 05, 2018

Higher Dose of Heparin Prevents Radial Artery Occlusion After Transradial Angiography

News Daily News

Higher Dose of Heparin Prevents Radial Artery Occlusion After Transradial Angiography

October 31, 2018

TCTMD’s Top 10 Most Popular Stories for October 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2018

October 31, 2018

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

News Daily News

Final Phase III Bempedoic Acid Trial Proves Positive for LDL-Lowering

October 29, 2018

Patients With Chest Pain Less Likely to Die After Discharge From High-Volume EDs

News Daily News

Patients With Chest Pain Less Likely to Die After Discharge From High-Volume EDs

October 26, 2018

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

News Daily News

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Michael O'Riordan

October 25, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.